Skip to content

CEDARS MEDICAL

Active
Private limited company (pre-2019)founded 200620 yrs activeRue de Fernelmont(CH) 122, 5020 Namur, BelgiumKBO/BCE: BE 0882.809.767

CEDARS MEDICAL has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €303k and a net result of €72k. Equity is growing by ~8.8% per year across the filed fiscal years. Its solvency ranks better than 64% of 4555 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
78 / 100
Excellent▼ -22 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency78▼-20
Growth78=
Stability100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €24k at 30 days acceptable
Liquidity tight (current ratio 1.43 against 2.78 in 2024), and 54.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 20 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
45.9%
Return on assets
11%
Age of the figures
8 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
59 d early
2024
37 d early
2023
125 d early
2022
124 d early
2021
164 d early
2020
39 d early
2019
113 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€303k▼ 24.6%
2024 · €402k
2018: €162k 2019: €220k 2020: €218k 2021: €226k 2022: €247k 2023: €295k 2024: €402k
2018 → 2025
Total assets
€660k▼ 1.0%
2024 · €667k
2018: €642k 2019: €632k 2020: €627k 2021: €616k 2022: €649k 2023: €655k 2024: €667k
2018 → 2025
Net result
€72k▼ 56.2%
2024 · €165k
2018: €-206 2019: €58k 2020: €56k 2021: €47k 2022: €68k 2023: €51k 2024: €165k
2018 → 2025
Working capital
€111k▼ 50.4%
2024 · €223k
2018: €20k 2019: €61k 2020: €50k 2021: €60k 2022: €72k 2023: €76k 2024: €223k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€226k-€247k▲ 9.1%€295k▲ 19.4%€402k▲ 36.4%€303k▼ 24.6%
Operating result€85k-€108k▲ 26.1%€85k▼ 20.7%€230k▲ 169%€114k▼ 50.3%
Net result€47k-€68k▲ 44.7%€51k▼ 24.6%€165k▲ 223%€72k▼ 56.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200kOperating result 2021: €85k€85kNet result 2021: €47k€47kOperating result 2022: €108k€108kNet result 2022: €68k€68kOperating result 2023: €85k€85kNet result 2023: €51k€51kOperating result 2024: €230k€230kNet result 2024: €165k€165kOperating result 2025: €114k€114kNet result 2025: €72k€72k20212022202320242025
The operating result falls in 2025; 2025 is 50% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €660k
Fixed assets €295k▼ 7.4%
Current assets €365k▲ 4.8%
Equity and liabilities €660k
Equity €303k▼ 24.6%
Debt €357k▲ 34.7%
The debt ratio rises from 39.7% to 54.1%: debt grows while equity shrinks.
Key figures and ratios
2025 value · change against 2024
EBITDA
€139k
2024 · €261k
Cash flow
€97k
2024 · €197k
Solvency
45.9%
2024 · 60.3%
Current ratio
1.43
2024 · 2.78
Quick ratio
1.43
2024 · 2.78
Debt / equity
1.18
2024 · 0.66
ROE
23.9%
2024 · 41.1%
ROA
11.0%
2024 · 24.8%
Interest coverage
16.64
2024 · 48.60
Debt
€357k
2024 · €265k
Debt ≤ 1 year
€255k
2024 · €125k
Debt > 1 year
€102k
2024 · €140k
Income taxes
€37k
2024 · €63k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€667k€660k
Fixed assets21/28€319k€295k
Tangible fixed assets22/27€319k€295k
Land and buildings22€283k€263k
Plant, machinery and equipment23€1k€1k
Other tangible fixed assets26€34k€31k
Financial fixed assets28€45€45=
Current assets29/58€349k€365k
Amounts receivable within one year40/41€35k€64k
Other amounts receivable41€35k€64k
Current investments50/53€11k€9k
Cash at bank and in hand54/58€299k€288k
Deferred charges and accrued income490/1€3k€4k
Equity and liabilities
Total equity and liabilities10/49€667k€660k
Equity10/15€402k€303k
Contributions10/11€12k€12k=
Reserves13€390k€291k
Distributable reserves133€390k€291k
Amounts payable17/49€265k€357k
Amounts payable after more than one year17€140k€102k
Financial debts170/4€140k€102k
Amounts payable within one year42/48€125k€255k
Current portion of amounts payable after more than one year42€37k€37k
Trade debts44€7k€7k
Suppliers440/4€7k€7k
Taxes, remuneration and social security45€19k€40k
Taxes450/3€19k€40k
Other amounts payable47/48€63k€171k
Accrued charges and deferred income492/3-€90
Income statement Code20242025
Non-recurring operating income76A€182k-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€32k€25k
Other operating charges640/8€384€403
Gross operating margin9900€262k€140k
Operating profit (loss)9901€230k€114k
Financial income75/76B€4k€4k
Recurring financial income75€4k€4k
Financial charges65/66B€5k€8k
Recurring financial charges65€5k€8k
Profit (loss) for the period before taxes9903€228k€110k
Income taxes67/77€63k€37k
Profit (loss) for the period9904€165k€72k
Profit (loss) for the period to be appropriated9905€165k€72k
Appropriation of the result
Profit (loss) to be appropriated9906€165k€72k
Transfer from equity791/2€58k€171k
Transfer to equity691/2€165k€72k
To other reserves6921€165k€72k
Profit to be distributed694/7€58k€171k
Return on contributions (dividend)694€58k€171k

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
02-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
24-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2018net €165k ▲223%
Operating result €230k, net result €165k, both a record.
28-03
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
29-03
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
17-02
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
22-06
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
09-04
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial Back to profitnet €58k
Net result €58k after one loss-making year.
31-12
Financial Equity above €200kEq €220k ▲35.2%
Equity rises from €162k to €220k.
24-06
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
23-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 23 days late
2017
21-08
NBB filing Annual accounts filed
fiscal year 2016 · micro schema · 21 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
no sitting director, no change since 2024
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
24-01-2024 Resigned as Manager
Location & real-estate footprint
Registered office, Namur · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue de Fernelmont(CH) 1225020 Namur
Ground area
4,157 m²
Building footprint
712 m²
Volume, LiDAR
12,131 m³
2 parcels, Wallonia · tallest building 25.3 m, ±7 floors. Linked by address, not a title deed.
1 establishment unit
Boulevard Isabelle Brunell 2, 5000 Namur
Specialist medical practice
since 20182.281.850.863
2 parcels
Wallonia 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
92024D0384/00Y000 Wallonia 3,434 m² 1 · 264 m² 10.8 m · 3 fl.
92094C0482/00L002 Wallonia 723 m² 1 · 448 m² 25.3 m · 7 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Connections & network

1 connected company
Network connections
CEDARS IMMO
Shared address

Recognitions · licences · registrations

Legal Entity Identifier

98450074F7B8E5P4FB80
live in the LEI register

Similar companies · same sector, comparable size

Of 24,812 companies in sector 96220 we hold annual accounts for 1,426. 664 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company (pre-2019)
Founded01-08-2006
Fiscal year end31-12
Activities, NACEBEL
96022Beauty treatment
96220Beauty care and other beauty treatments
Sources
Crossroads Bank for EnterprisesNational Bank · 19 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.